Edgewise Therapeutics files amended 8-K with unaudited pro forma financials for Servier asset salePUBT·Jul 16 at 07:02 AMEWTX-6.54%
Edgewise Therapeutics Sells Muscular Dystrophy Assets to ServierTip Ranks·Jul 13 at 12:28 PMEWTX-6.54%
Edgewise Therapeutics Completes Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline | EWTX Stock NewsStockTitan·Jul 12 at 11:30 PMEWTX-6.54%
Top Edgewise Therapeutics Executive Makes Major Move With Insider Stock SaleTip Ranks·Jul 2 at 09:05 PMEWTX-6.54%
Edgewise Therapeutics CSO Alan J. Russell sells 200,000 common shares worth $7.88 millionPUBT·Jul 2 at 04:21 PMEWTX-6.54%
Edgewise Therapeutics grants inducement stock options for 16,500 shares at $40.63 eachPUBT·Jul 1 at 07:05 AMEWTX-6.54%
Delta Air Lines To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Wednesdaybenzinga_article·Jun 17 at 08:05 AMDAL-1.30%RMD+1.16%
Cytokinetics: Competitive Overhang Eases After EDG-7500 Data, Analyst Reiterates Buy and $102 Price TargetTip Ranks·Jun 16 at 02:55 PMCYTK-4.09%EWTX-6.54%
Edgewise Therapeutics Reports Improvements In Heart Drug Trialbenzinga_article·Jun 16 at 12:40 PMEWTX-6.54%
